Clinical Trial Update: The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria [Phase 4]

View source ↗

Summary

A completed Phase 4 study assessing the effect of renin-angiotensin system blockade on PTX3 levels in diabetic patients with proteinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Nephropathy

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Diabetes, Proteinuria | Phase 4 | Status: COMPLETED